Michael G. Kurilla, MD, PhD
Director Office of BioDefense Research Affairs, National Institute of Allergy and Infectious Diseases (NIAID)
Dr. Kurilla describes the key contributions of the National Institute of Allergy and Infectious Diseases to US biosecurity, including early stage research and development of drugs and vaccines, and transitioning candidate products to the most appropriate federal or industry partners for further development. Dr. Kurilla offers insight on how development timelines could be shortened, and he suggests that one way to increase the nation’s medical preparedness to biological threats could be to explore methods to enhance the host immune response, as opposed to focusing on a “one-bug-one-drug” approach.
Video produced by the Center for Biosecurity of UPMC